Quantbot Technologies LP Mersana Therapeutics, Inc. Transaction History

Quantbot Technologies LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.11 - $2.34 $12,148 - $25,611	10,945 New	10,945 $25,000
Q2 2022 Aug 09, 2022	SELL	$2.84 - $5.0 $23,856 - $42,000	-8,400 Reduced 89.8%	954 $4,000
Q1 2022 May 16, 2022	BUY	$3.74 - $6.63 $34,983 - $62,017	9,354 New	9,354 $37,000
Q3 2021 Nov 09, 2021	SELL	$8.56 - $14.47 $138,672 - $234,414	-16,200 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$13.28 - $18.07 $215,136 - $292,734	16,200 New	16,200 $219,000
Q4 2020 Feb 12, 2021	SELL	$16.84 - $27.59 $8,420 - $13,795	-500 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$16.2 - $25.7 $8,100 - $12,850	500 New	500 $9,000

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $198M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.